University Of Birmingham

- Country
- 🇸🇪Sweden
- Ownership
- Private
- Established
- 1900-05-01
- Employees
- 5K
- Market Cap
- -
Clinical Trials
583
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (502 trials with phase data)• Click on a phase to view related trials
Reducing Deaths After Surgery in Low- and Middle-income Countries: A Pilot Cluster Randomised Trial
- Conditions
- Post-operative Complications
- First Posted Date
- 2025-04-17
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- University of Birmingham
- Target Recruit Count
- 300
- Registration Number
- NCT06932653
- Locations
- 🇧🇯
University of Abomey-Calavi, Abomey-Calavi, Cotonou, Benin
🇬🇭Tamale Teaching Hospital, Tamale, Tamale, Ghana
🇮🇳Christian Medical College (CMC) & Hospital, Ludhiana, Ludhiana, 141008, Ludhiana, India
De-stressing the Brain: Can Eating Grapes During Periods of Mental Stress Protect Brain and Vascular Health in Young Adults
- Conditions
- Healthy
- First Posted Date
- 2025-04-11
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- University of Birmingham
- Target Recruit Count
- 44
- Registration Number
- NCT06923722
- Locations
- 🇬🇧
School of Sport, Exercise & Rehabilitation Sciences, Birmingham, United Kingdom
A Global Prospective Cohort Study on Outcomes of Appendicectomy for Appendicitis
- Conditions
- AppendicitisAppendectomy
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- University of Birmingham
- Target Recruit Count
- 14000
- Registration Number
- NCT06774001
- Locations
- 🇿🇦
Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa
🇧🇯University of Abomey Calavi, Cotonou, Benin
🇬🇭Tamale Teaching Hospital, Tamale, Ghana
Mpox Comprehensive Assessment for Responsive Immunisation in Emergency Outbreaks
- Conditions
- Mpox
- First Posted Date
- 2025-03-20
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- University of Birmingham
- Target Recruit Count
- 650
- Registration Number
- NCT06887556
- Locations
- 🇷🇼
Rwanda Biomedical Center, Kigali, Rwanda
Safety and Immunogenicity of rVSVΔG-ZEBOV-GP Vaccination When Dosed Concurrently With mRNA COVID-19 Vaccine Booster Doses
- Conditions
- Ebola Virus DiseaseCOVID-19
- Interventions
- Biological: 1mL saline solutionBiological: BioNTech - Pfizer COVID-19 vaccineBiological: rVSV∆G-ZEBOV-GP
- First Posted Date
- 2024-09-09
- Last Posted Date
- 2024-09-16
- Lead Sponsor
- University of Birmingham
- Target Recruit Count
- 72
- Registration Number
- NCT06587503
- Prev
- 1
- 2
- 3
- 4
- 5
- 34
- Next
News
GLP-1 Diabetes Drug Liraglutide Reduces Migraine Days by Half in Pilot Study
A 12-week pilot study of 26 adults with obesity and chronic migraines found that liraglutide, a GLP-1 diabetes drug, reduced average monthly headache days from 20 to approximately 9.
Linear Diagnostics Secures £1M to Advance 5-Minute STI Diagnostic Test
Linear Diagnostics has received £1 million in NIHR funding to develop a rapid diagnostic test that can detect sexually transmitted infections in as little as five minutes using their Exponential Amplification technology.
Smartwatch Innovation: New Heart Rate-to-Step Ratio Emerges as Superior Health Indicator
Northwestern University researchers have developed a new health metric that divides average daily heart rate by step count, providing a more reliable measure of cardiovascular fitness than either measurement alone.
PFAS "Forever Chemicals" Contaminate Drinking Water for 75-95 Million Americans, USGS Study Reveals
More than 20% of Americans in the continental U.S. rely on groundwater containing detectable levels of PFAS chemicals, according to a comprehensive new USGS study published in Science Advances.
Dual-Modal Approach Combining OCT and Raman Spectroscopy Achieves 97% Accuracy in Skin Cancer Detection
A novel dual-modal approach combining optical coherence tomography (OCT) and Raman spectroscopy has demonstrated 96.9% accuracy in differentiating melanoma from benign lesions when paired with machine learning algorithms.
Study Finds No Benefit in Pausing BTK Inhibitors During COVID-19 Vaccination for CLL Patients
A clinical trial led by the University of Birmingham reveals that chronic lymphocytic leukemia patients should continue Bruton Tyrosine Kinase inhibitor therapy during COVID-19 vaccination, contradicting previous observational studies.
Vancomycin Shows Promise in Treating PSC-Associated Inflammatory Bowel Disease
A University of Birmingham study reveals that vancomycin, a common antibiotic for diarrhea, achieved 80% clinical remission in patients with PSC-associated inflammatory bowel disease after four weeks of treatment.
University of Birmingham Pioneers Personalized Cancer Treatment Approaches with Novel Technologies
University of Birmingham researchers are revolutionizing cancer diagnosis through innovative MRI and machine learning techniques that can identify pediatric brain tumor types in just ten minutes.
Digoxin Shows Cost-Effectiveness Over Beta-Blockers in Heart Failure Treatment, UK Study Finds
A University of Birmingham study reveals digoxin could save the NHS £100m annually compared to beta-blockers in treating elderly patients with heart failure and atrial fibrillation.
MRI Scans Significantly Reduce Time to Treatment for Aggressive Bladder Cancer
A new study reveals that using MRI scans for initial diagnosis of muscle-invasive bladder cancer can reduce the time to treatment by over six weeks.